Polly Weight Loss Review 2026: How It Works, Cost, and Who It Fits

What Is Polly?

Polly (joinpolly.com) is a direct-to-consumer telehealth platform for prescription weight loss. It connects patients with independent licensed healthcare providers who evaluate eligibility and, when medically appropriate, prescribe compounded GLP-1 medications that partner 503A compounding pharmacies prepare and ship to the patient's door. Polly states it works with pharmacies including Hallandale Pharmacy and VialsRx, operates in all 50 states, and runs on a self-pay basis — it does not bill insurance, though its site says HSA/FSA reimbursement may be available depending on your plan.

The name is new; the company is not. Polly is the rebrand of Piper, completed in late April 2026 — the site's own footer still reads “© 2026 Piper Wellness LLC d/b/a JoinPolly.” That rebrand is why searching “Polly weight loss reviews” turns up so little: the company's review history mostly lives under the old Piper name.

How the Polly Program Works, From Signup to Shipment

Polly follows the standard structure for legitimate compounded GLP-1 telehealth: online intake, an independent provider's clinical review, pharmacy compounding, and home delivery. Here is the flow as Polly's own site describes it, verified August 2026.

Polly's site sketches a treatment arc familiar to anyone researching GLP-1s: an adjustment period in the first three months as appetite and portions change, plan adjustments and habit-building from months three to six, and maintenance-focused support beyond that. That framing is reasonable — GLP-1 therapy is long-term treatment, not a short course — which is also why the pricing structure you pick matters more than any single month's bill.

One more experience note: Polly actively markets to people switching from other providers (its site calls this a “Switch Commitment”). If you're considering a move in either direction, our guide on how to switch GLP-1 providers covers the handoff details — records, dose continuity, and timing — that make a switch smooth.

What Polly Costs in 2026 (Verified August 2026)

Polly's advertised pricing is genuinely simple in structure: all-inclusive, no separate membership fee, the same price at every dose, and next-day shipping included. As of our August 2026 check of Polly's own treatment pages:

• Compounded semaglutide: advertised from $135 per 4-week supply, displayed against a crossed-out $199 list price.

• Compounded tirzepatide: advertised from $199 per 4-week supply, displayed against a crossed-out $279 list price.

• Payment: self-pay only (no insurance billed), HSA/FSA reimbursement may be available per Polly's FAQ, and a pay-over-time financing option is advertised on its treatment pages.

The word to slow down on is “from.” A crossed-out list price next to a lower headline number is a discount-anchored pricing pattern: the rate you're actually offered at checkout can depend on which plan you select, and the deepest rates in this category are typically tied to longer or multi-month plans. That isn't unique to Polly, and it isn't inherently unfair — but it means the headline is a starting point, not a quote. Before you pay, confirm three numbers: the exact monthly rate for your plan, the total charged upfront today, and the renewal terms. Multi-month billing is common across the category — our guide to 3-month GLP-1 supplies explains how those shipments and charges typically work.

For the wider market context — what each billing model really adds up to across providers — see our compounded semaglutide cost guide and compounded tirzepatide cost guide.

What Medications Does Polly Provide?

Polly's treatment menu, per its homepage in August 2026, centers on two once-weekly GLP-1 injections — compounded semaglutide and compounded tirzepatide — alongside wellness add-ons: sermorelin, lipotropic MIC+B12 injections, and NAD+ in both spray and vial form. The GLP-1s are the weight-loss core; the add-ons are optional extras that a provider would evaluate separately.

All of these are compounded products: prepared per individual prescription by a state-licensed pharmacy and not FDA-approved as drugs. Credit to Polly here — its own site carries a clear disclosure stating its formulations are not FDA-approved, have not undergone their own clinical trials, and are not substitutes for FDA-approved medications. That is the correct, honest framing for this entire category, including Trimi's medications, which carry the same compounded status.

What published evidence exists comes from trials of the FDA-approved products, not of compounded preparations. According to the STEP 1 trial published in the New England Journal of Medicine (2021), participants taking semaglutide 2.4 mg averaged a 14.9% body-weight reduction over 68 weeks alongside lifestyle changes. The SURMOUNT-1 trial (NEJM, 2022) reported up to 20.9% average body-weight reduction at the highest tirzepatide dose over 72 weeks. Compounded preparations have not been studied in trials of their own, and individual results vary.

Polly vs Trimi: Side by Side

This is an unusually direct comparison because both companies work with the same compounding pharmacy: VialsRx, one of Polly's two named 503A partners, is the same Texas 503A sterile compounding pharmacy that prepares Trimi's medications (Trimi also works with GreenwichRx, and publishes VialsRx's Texas State Board of Pharmacy license, #35264). The differences are about pricing structure, verifiability, and clinical infrastructure — not wildly different supply chains.

On the numbers: if Polly's deepest advertised rates are what you'd actually pay, Trimi's flat $99/mo semaglutide still runs $36/mo less than Polly's from-$135 rate (about $432 over a year), and $125/mo tirzepatide runs $74/mo less than Polly's from-$199 rate (about $888 over a year) — with no checkout-tier fine print to decode, since Trimi's rate is the published price at every dose. Trimi (founded May 2024, headquartered in New York City) also publishes the license number of its compounding pharmacy, which you can verify yourself through the Texas State Board of Pharmacy.

Both models are legitimate, and Polly's same-price-at-every-dose structure genuinely protects patients from dose-escalation cost creep — a real problem elsewhere in this market, as our Mochi Health review shows with its separate $79/month membership-fee model. The Polly-vs-Trimi decision mostly comes down to how much pricing certainty you want before checkout.

Who Polly Fits — and Who a Flat-Price Model Fits

Whichever direction you lean, the medication category and the pharmacy layer overlap heavily between these two providers — so let the pricing structure, commitment terms, and transparency you're comfortable with make the call. And before enrolling anywhere, read the plan terms on the checkout page itself, not just the landing page.

What to Expect Clinically, Whichever Provider You Choose

The active medications drive outcomes far more than the platform brand does. Semaglutide and tirzepatide are GLP-1 receptor agonists (tirzepatide adds GIP receptor activity) that reduce appetite and slow gastric emptying; the trial figures cited above come from the FDA-approved products. Compounded versions have no trials of their own, and individual results vary with dose, adherence, diet, activity, and clinical support.

Common side effects — nausea, constipation, diarrhea, reduced appetite — are usually most noticeable during dose titration in the first months. Serious but less common risks include pancreatitis, gallbladder disease, and kidney injury, and both medications carry a boxed warning for thyroid C-cell tumors observed in rodent studies. Per FDA guidance on drug compounding, compounded preparations are not reviewed by the agency for safety or effectiveness before marketing — which is why provider oversight and a state-licensed pharmacy are non-negotiable wherever you enroll. A licensed provider should be actively managing your titration; if that isn't happening, treat it as a quality signal.

Frequently Asked Questions About Polly